In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells

Aim. In Crohn's disease (CD), anti-TNF-α treatment is a potent medication. We aimed to characterize the effect of anti-TNF-α treatment on T effector and regulatory cells. Material and Methods. We studied T-effector and regulatory cells on cellular and mRNA levels in intestinal biopsy samples fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hölttä, Veera, Sipponen, Taina, Westerholm-Ormio, Mia, Salo, Harri M., Kolho, Kaija-Leena, Färkkilä, Martti, Savilahti, Erkki, Vaarala, Outi, Klemetti, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384926/
https://www.ncbi.nlm.nih.gov/pubmed/22778976
http://dx.doi.org/10.5402/2012/505432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384926/
https://www.ncbi.nlm.nih.gov/pubmed/22778976
http://dx.doi.org/10.5402/2012/505432

Ejemplares similares